Drug Type Small molecule drug |
Synonyms D-CPP-ENE, D-CPPene, SDZ-EAA-494 |
Target |
Mechanism NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H15N2O5P |
InChIKeyVZXMZMJSGLFKQI-ABVWVHJUSA-N |
CAS Registry117414-74-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Midafotel | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Injuries | Phase 3 | CH | - | |
Brain Injuries | Phase 3 | - | - | |
Cognition Disorders | Phase 1 | CH | - | |
Epilepsy | Phase 1 | CH | - | |
Epilepsy | Phase 1 | GB | - |